Creso Pharma Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COPHF research report →
Price Chart
About the company
Creso Pharma Limited is a global pharmaceutical company focused on the development, registration, and commercialization of advanced cannabis and hemp-based solutions. These therapeutic products and nutraceuticals are designed for both human and animal health applications, with market presence spanning Europe, the Middle East, North America, and the Asia Pacific region. Beyond innovative product creation, the company also manages the cultivation, processing, and distribution of cannabis products, extending its reach to the retail sector.
- CEO
- William Lay
- IPO
- 2017
- HQ
- Nedlands, WA, AU
Get TickerSpark's AI analysis on COPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $131.72M
- P/E
- -0.40
- PEG
- -0.00
- P/S
- 2.66
- P/B
- 0.59
- EV/EBITDA
- -0.94
- Div Yield
- 0.00%
- Gross Margin
- 3.30%
- Op Margin
- -225.19%
- Net Margin
- -377.28%
- ROE
- -130.99%
- ROIC
- -67.55%
Latest fiscal year · YoY change
- Revenue
- $18.92M+117.8%
- Gross Profit
- $2.33M+713.6%
- Op Income
- $-16,680,000
- Net Income
- $-52,446,000-60.0%
- EPS
- $0.00+100.0%
- OCF Growth
- +100.0%
- FCF Growth
- +72.9%
- 52W High
- $9.47
- 52W Low
- $0.00
- 50D MA
- $0.12
- 200D MA
- $0.07
- Beta
- -24.81
- RSI (14)
- 35
- Avg Volume
- 0
No earnings-call transcripts are available for COPHF yet.
- Free Float
- 1.2%
- Shares Outstanding
- 1.13B
- Float Shares
- 13.06M
Our COPHF coverage
Recent articles, reports, and earnings notes.
No research on COPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COPHF report →Melodiol Global Health Stock Scheduled to Reverse Split on Wednesday, June 5th (OTCMKTS:COPHF)
https://www.defenseworld.net · May 20
Cannabis stocks slump on SAFE Banking Act Senate hearing and mixed quarterly earnings
proactiveinvestors.com · May 12
Creso Pharma psychedelics subsidiary Halucenex Life Sciences broadens scope ahead of Phase 2 clinical trials
proactiveinvestors.com · Jul 18
Creso Pharma subsidiary on official list to provide psilocybin to Canadian doctors
proactiveinvestors.com · Feb 7
Australian Creso Pharma To Enter US CBD Market Via $21M Acquisition Of Sierra Sage Herbs
benzinga.com · Feb 4
Creso Pharma pushes into US CBD market with revenue-generating acquisition
proactiveinvestors.com · Feb 2
Creso Pharma psychedelics subsidiary Halucenex lodges CTA to test efficacy of psilocybin on treatment-resistant PTSD
proactiveinvestors.com · Jan 24
Creso Pharma has eye on North America with new crop of cannabis-credentialled executives
proactiveinvestors.com · Jan 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.